Bendamustine-containing immunochemotherapy is active in transformed follicular lymphoma with overexpression of p53.
Sanchez-Gonzalez
Blanca
B
Department of Hematology, Hospital del Mar, Barcelona, Spain. 97894@imas.imim.es
Garcia
Mar
M
Serrano
Sergi
S
Besses
Carles
C
Salar
Antonio
A
D000368:Aged; D000069461:Bendamustine Hydrochloride; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000628:therapy*; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use*; D012008:Recurrence; D012074:Remission Induction; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*
D009588:Nitrogen Mustard Compounds; D016159:Tumor Suppressor Protein p53; D000069461:Bendamustine Hydrochloride